Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2025
2024
2023
2022
2024
2024-02-27 09:25
BioStock publishes interview of Prolight Diagnostics CTO Steve Ross
2024-02-23 11:10
Biostock publishes article about Prolight Diagnostics Q4 report
2024-02-21 08:00
Prolight Diagnostics publishes year-end report 2023
Regulatory
MAR
2024-02-05 08:20
Emergers initiates equity research coverage of Prolight Diagnostics
2024-01-29 09:40
Biostock publishes article about the high interest of POC systems and the latest acquisitions on the market
2024-01-10 08:00
Prolight announces last day of trading in BTU and first day of trading in warrants of series TO6 and TO7
Regulatory
2024-01-09 18:30
Correction: Incorrectly applied MAR-label in previous press release. Prolight’s Board of Directors have decided to carry out a directed issue of units to underwriters in connection with the completed rights issue
Regulatory
2024-01-09 14:45
Prolight’s Board of Directors have decided to carry out a directed issue of units to underwriters in connection with the completed rights issue
Regulatory
MAR
Previous